Fig. 5From: The role of chemotherapy in patients with stage IB gastric adenocarcinoma: a real-world competing risk analysisCumulative incidence curves for the stage IB GAC patients according to chemotherapy in different subgroups before and after PSM. T1 (A), T2a (B), RNE1-15 (C), RNE>16 (D), without radiation (E), and with radiation (F) cohorts before PSM. T1 (G), T2a (H), RNE1-15 (I), RNE>16 (J), without radiation (K), and with radiation (L) cohorts after PSMBack to article page